Patterns and costs associated with glucagon-like peptide-1 receptor agonist use in US adults with type 2 diabetes
{{output}}
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) offer cardiorenal benefits in diabetes management. Since 2020, public awareness of GLP-1 RAs for diabetes, weight loss, and the prevention of cardiovascular diseas... ...
